236 related articles for article (PubMed ID: 25730815)
1. Dengue fever: natural management.
Qadir MI; Abbas K; Tahir M; Irfan M; Raza Bukhari SF; Ahmed B; Hanif M; Rasul A; Ali M
Pak J Pharm Sci; 2015 Mar; 28(2):647-55. PubMed ID: 25730815
[TBL] [Abstract][Full Text] [Related]
2. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
[TBL] [Abstract][Full Text] [Related]
3. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
4. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
5. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in understanding dengue virus replication.
Urcuqui-Inchima S; Patiño C; Torres S; Haenni AL; Díaz FJ
Adv Virus Res; 2010; 77():1-39. PubMed ID: 20951868
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of prochlorperazine for use against dengue virus infection.
Simanjuntak Y; Liang JJ; Lee YL; Lin YL
J Infect Dis; 2015 Feb; 211(3):394-404. PubMed ID: 25028694
[TBL] [Abstract][Full Text] [Related]
8. Betulinic acid exhibits antiviral effects against dengue virus infection.
Loe MWC; Hao E; Chen M; Li C; Lee RCH; Zhu IXY; Teo ZY; Chin WX; Hou X; Deng J; Chu JJH
Antiviral Res; 2020 Dec; 184():104954. PubMed ID: 33080251
[TBL] [Abstract][Full Text] [Related]
9. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1.
Chen WC; Tseng CK; Lin CK; Wang SN; Wang WH; Hsu SH; Wu YH; Hung LC; Chen YH; Lee JC
Virulence; 2018 Jan; 9(1):588-603. PubMed ID: 29338543
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of lanatoside C against dengue virus infection.
Cheung YY; Chen KC; Chen H; Seng EK; Chu JJ
Antiviral Res; 2014 Nov; 111():93-9. PubMed ID: 25251726
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing approaches to fight Dengue virus infection and related diseases.
Botta L; Rivara M; Zuliani V; Radi M
Front Biosci (Landmark Ed); 2018 Jan; 23(6):997-1019. PubMed ID: 28930586
[TBL] [Abstract][Full Text] [Related]
12. Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation.
Uchida L; Urata S; Ulanday GE; Takamatsu Y; Yasuda J; Morita K; Hayasaka D
Viruses; 2016 Feb; 8(2):. PubMed ID: 26875984
[TBL] [Abstract][Full Text] [Related]
13. (E)-Guggulsterone Inhibits Dengue Virus Replication by Upregulating Antiviral Interferon Responses through the Induction of Heme Oxygenase-1 Expression.
Chen WC; Wei CK; Hossen M; Hsu YC; Lee JC
Viruses; 2021 Apr; 13(4):. PubMed ID: 33924157
[TBL] [Abstract][Full Text] [Related]
14. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
Melino S; Paci M
FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
[TBL] [Abstract][Full Text] [Related]
15. Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes.
Sood R; Raut R; Tyagi P; Pareek PK; Barman TK; Singhal S; Shirumalla RK; Kanoje V; Subbarayan R; Rajerethinam R; Sharma N; Kanaujia A; Shukla G; Gupta YK; Katiyar CK; Bhatnagar PK; Upadhyay DJ; Swaminathan S; Khanna N
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004255. PubMed ID: 26709822
[TBL] [Abstract][Full Text] [Related]
16. Melatonin Inhibits Dengue Virus Infection via the Sirtuin 1-Mediated Interferon Pathway.
Morchang A; Malakar S; Poonudom K; Noisakran S; Yenchitsomanus PT; Limjindaporn T
Viruses; 2021 Apr; 13(4):. PubMed ID: 33920458
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication.
Panda K; Alagarasu K; Parashar D
Molecules; 2021 Feb; 26(4):. PubMed ID: 33670247
[TBL] [Abstract][Full Text] [Related]
18. Dengue virus vaccine development.
Yauch LE; Shresta S
Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.
Smith JL; Stein DA; Shum D; Fischer MA; Radu C; Bhinder B; Djaballah H; Nelson JA; Früh K; Hirsch AJ
J Virol; 2014 May; 88(10):5533-42. PubMed ID: 24599995
[TBL] [Abstract][Full Text] [Related]
20. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
Laosutthipong C; Kanthong N; Flegel TW
Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
